• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Alzheimers Dis . COVID-19 Case Fatality and Alzheimer's Disease

tetano

Editor, Senior Moderator
J Alzheimers Dis


. 2021 Oct 20.
doi: 10.3233/JAD-215161. Online ahead of print.
COVID-19 Case Fatality and Alzheimer's Disease


Qiang Zhang[SUP] 1 [/SUP], Jordan L Schultz[SUP] 1 2 [/SUP], Georgina M Aldridge[SUP] 1 [/SUP], Jacob E Simmering[SUP] 3 [/SUP], Youngcho Kim[SUP] 1 [/SUP], Amy C Ogilvie[SUP] 2 4 [/SUP], Nandakumar S Narayanan[SUP] 1 [/SUP]



Affiliations

Abstract

Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an independent risk factor for COVID-19 case fatality rate. In a retrospective cohort study, we identified 387,841 COVID-19 patients through TriNetX. After adjusting for demographics and comorbidities, we found that AD patients had higher odds of dying from COVID-19 compared to patients without AD (Odds Ratio: 1.20, 95%confidence interval: 1.09-1.32, p < 0.001). Interestingly, we did not observe increased mortality from COVID-19 among patients with vascular dementia. These data are relevant to the evolving COVID-19 pandemic.

Keywords: Alzheimer’s disease; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); case fatality; dementia with Lewy bodies; frontotemporal dementia; vascular dementia.
 
Back
Top Bottom